As of Tuesday October 20th, a vital recommended treatment for heart failure is widely underused in many U.S. hospitals, a recent study noted. The use of aldosterone antagonist therapy in patients with heart failure is designated as “useful and recommended” in conditions chronic heart failure guidelines established by the American College of Cardiology and American Heart Association (ACC/AHA). The study currently found that less than 1/3 of patients hospitalized for heart failure receive this useful treatment.

Researchers initially evaluated data on more than 43,000 patients admitted to hospitals with heart failure and discharged home, with the majority not receiving this vital treatment. Researchers noted that almost 13,000 patients from more than 200 hospitals met ACC/AHA guidelines for heart failure management criteria, and only 5,000 of eligible patients received aldosterone antagonist treatment prior to being released. Several researchers spoke out and explained that the data collected confirmed the performance improvement needs in many hospitals when it comes to heart failure treatment mis-use. For many of these hospitals, researchers strongly suggested that a higher uptake of aldosterone antagonist therapy be implemented for treating heart failure in patients.

Staff – Everythingantiaging.com

Keep your heart strong with heart care supplements at great prices only at www.everythingantiaging.com